These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25318635)

  • 1. Social regulations predispose people to complete vaccination for vaccine-preventable diseases.
    Takeuchi J; Goto M; Kawamura T; Hiraide A
    Tohoku J Exp Med; 2014 Nov; 234(3):183-7. PubMed ID: 25318635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Vaccination dose and clinico-demographical factors on antibody titers against measles, rubella, mumps, and varicella-zoster viruses among university students in Japan.
    Takeuchi J; Goto M; Kawamura T; Hiraide A
    Jpn J Infect Dis; 2013; 66(6):497-502. PubMed ID: 24270137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
    Yoshida N; Tsumura N; Toyomasu K; Sagawa K
    Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of students' willingness to accept a measles-mumps-rubella booster vaccination during a mumps outbreak: a cross-sectional study.
    Donkers HW; Hautvast JL; Akkermans RP; Swaan CM; Ruijs WL; Hulscher ME
    BMC Public Health; 2015 Jun; 15():575. PubMed ID: 26092263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan.
    Kumakura S; Onoda K; Hirose M
    J Infect Chemother; 2014 Mar; 20(3):194-8. PubMed ID: 24462433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vaccine program on IgG antibody titers for measles, rubella, varicella, and mumps in young adults in Japan: Survey between 2018 and 2021.
    Miyazaki H; Yamanaka G; Furukawa K; Ichiki M
    J Infect Chemother; 2022 Oct; 28(10):1410-1414. PubMed ID: 35779802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.
    Uno Y; Uchiyama T; Kurosawa M; Aleksic B; Ozaki N
    Vaccine; 2012 Jun; 30(28):4292-8. PubMed ID: 22521285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
    Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E
    Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
    Sanftenberg L; Schrörs HJ; Schelling J
    Vaccine; 2016 Jul; 34(34):3938-41. PubMed ID: 27318420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new combination vaccine for measles, mumps, rubella and varicella.
    Zareba G
    Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women.
    Hanaoka M; Hisano M; Watanabe N; Sugawara K; Kambe Y; Kanda E; Sago H; Kato T; Yamaguchi K
    Vaccine; 2013 May; 31(19):2343-7. PubMed ID: 23523405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination coverage and immunity levels against vaccine-preventable diseases in male Air Force recruits in Greece.
    Maltezou HC; Karantoni H; Petrikkos P; Georgota P; Katerelos P; Liona A; Tsagarakis S; Theodoridou M; Hatzigeorgiou D
    Vaccine; 2020 Jan; 38(5):1181-1185. PubMed ID: 31761499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
    Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of medical and paramedical university students in Lebanon against measles, mumps, rubella and varicella: active measures are needed.
    Chamat S; Salameh P; Haddad N; Berry A; Chedid P; Bouharoun-Tayoun H
    J Infect Public Health; 2011 Aug; 4(3):125-34. PubMed ID: 21843858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
    Levine H; Zarka S; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Balicer RD
    Hum Vaccin Immunother; 2015; 11(6):1400-5. PubMed ID: 25891446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.